TSE:FRX Fennec Pharmaceuticals (FRX) Stock Price, News & Analysis → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free FRX Stock Alerts C$9.28 -0.16 (-1.70%) (As of 06/14/2024 ET) Add Compare Share Share Today's RangeC$9.28▼C$9.5650-Day RangeC$9.00▼C$15.0052-Week RangeC$9.00▼C$15.43Volume1,125 shsAverage Volume1,627 shsMarket CapitalizationC$253.39 millionP/E Ratio185.50Dividend Yield2.02%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades Get Fennec Pharmaceuticals alerts: Email Address Ad Traders AgencyHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.Click here to pay just $5 for a full year of Stealth Trades About Fennec Pharmaceuticals Stock (TSE:FRX)Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.Read More FRX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FRX Stock News HeadlinesJune 13 at 1:34 AM | americanbankingnews.comEquities Analysts Set Expectations for Fennec Pharmaceuticals Inc.'s Q2 2024 Earnings (TSE:FRX)May 14, 2024 | finanznachrichten.deFennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateApril 5, 2024 | finance.yahoo.comInsider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)April 1, 2024 | seekingalpha.comFRX:CA Fennec Pharmaceuticals Inc.March 23, 2024 | seekingalpha.comFennec Pharmaceuticals Inc. (FENC) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | finance.yahoo.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | finanznachrichten.deFennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business UpdateMarch 19, 2024 | ca.finance.yahoo.comStocks in play: Fennec Pharmaceuticals Inc.March 17, 2024 | markets.businessinsider.comFennec, Norgine Reach Licensing Deal To Commercialize Pedmarqsi In Europe, Australia, & New ZealandFebruary 29, 2024 | finance.yahoo.comFennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 ResultsFebruary 23, 2024 | finance.yahoo.comFENC Mar 2024 10.000 callFebruary 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Societal CDMO (SCTL)December 6, 2023 | finance.yahoo.comWith 31% stake, Fennec Pharmaceuticals Inc. (NASDAQ:FENC) seems to have captured hedge funds investors' interestDecember 1, 2023 | morningstar.comFennec Pharmaceuticals Inc FRXNovember 9, 2023 | seekingalpha.comFennec Pharmaceuticals Expands Possible TAM SignificantlyNovember 9, 2023 | finance.yahoo.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesNovember 7, 2023 | finance.yahoo.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call TranscriptNovember 7, 2023 | finance.yahoo.comQ3 2023 Fennec Pharmaceuticals Inc Earnings CallNovember 3, 2023 | benzinga.comPreview: Fennec Pharmaceuticals's EarningsNovember 1, 2023 | finance.yahoo.comInvestors in Fennec Pharmaceuticals (NASDAQ:FENC) have unfortunately lost 20% over the last yearOctober 30, 2023 | finance.yahoo.comFennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023October 5, 2023 | finance.yahoo.comAnalysts Expect Breakeven For Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Before LongSeptember 30, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc up on Friday (FRX)August 23, 2023 | theglobeandmail.comFennec Pharmaceuticals: Top 10 Undervalued Healthcare Sector Stocks on TSX (FRX)May 25, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc down on Wednesday (FRX)See More Headlines Receive FRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today6/16/2024Next Earnings (Estimated)8/01/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:FRX CUSIPN/A CIKN/A Webfennecpharma.com Phone+1-919-6364530FaxN/AEmployees29Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C$0.05 Trailing P/E Ratio185.50 Forward P/E Ratio7.76 P/E GrowthN/ANet IncomeC$2.84 million Net Margins6.33% Pretax MarginN/A Return on Equity-1,005.59% Return on Assets8.57% Debt Debt-to-Equity Ratio1,040.68 Current Ratio6.93 Quick Ratio10.17 Sales & Book Value Annual SalesC$44.95 million Price / Sales5.64 Cash FlowC$0.80 per share Price / Cash Flow11.66 Book ValueC$0.11 per share Price / Book84.32Miscellaneous Outstanding Shares27,320,000Free FloatN/AMarket CapC$253.39 million OptionableNot Optionable Beta0.46 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Rostislav Raykov (Age 48)CEO & Director Comp: $1.2MMr. Robert C. Andrade (Age 49)Chief Financial Officer Comp: $817.74kMr. Adrian J. Haigh (Age 65)Chief Operating Officer Comp: $886.92kMr. Mark GowlandControllerMr. Lei FangPresident of Pharstat IncKey CompetitorsProMetic Life SciencesTSE:PLIVIVO CannabisCVE:ABCNEmblemCVE:EMCMedicenna TherapeuticsTSE:MDNABriaCell TherapeuticsCVE:BCTView All CompetitorsInsidersAdrian J. HaighSold 22,223 sharesTotal: C$207,029.47 ($9.32/share)Adrian J. HaighBought 22,222 shares on 4/15/2024Total: C$51,332.82 ($2.31/share)Chris Anigeron RallisSold 800 sharesTotal: C$8,360.00 ($10.45/share)Robert Christopher AndradeSold 13,975 sharesTotal: C$152,345.67 ($10.90/share)Chris Anigeron RallisSold 2,114 sharesTotal: C$23,190.58 ($10.97/share)View All Insider Transactions FRX Stock Analysis - Frequently Asked Questions How have FRX shares performed in 2024? Fennec Pharmaceuticals' stock was trading at C$15.16 at the beginning of 2024. Since then, FRX shares have decreased by 38.8% and is now trading at C$9.28. View the best growth stocks for 2024 here. When is Fennec Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024. View our FRX earnings forecast. How were Fennec Pharmaceuticals' earnings last quarter? Fennec Pharmaceuticals Inc. (TSE:FRX) issued its quarterly earnings results on Tuesday, May, 14th. The biopharmaceutical company reported $0.56 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.67 by $0.11. The biopharmaceutical company earned $34.21 million during the quarter, compared to analysts' expectations of $14.19 million. Fennec Pharmaceuticals had a negative trailing twelve-month return on equity of 1,005.59% and a net margin of 6.33%. What other stocks do shareholders of Fennec Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Fennec Pharmaceuticals investors own include Encanto Potash (EPO), Acadian Timber (ADN), Agellan Commercial Real Estate Invtmt TR (ACR.UN), AutoCanada (ACQ), ATCO (ACO.X), Accord Financial (ACD), Aurora Cannabis (ACB), Air Canada (AC) and Barrick Gold (ABX). How do I buy shares of Fennec Pharmaceuticals? Shares of FRX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:FRX) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredBitcoin’s Biggest Year Yet2024 is set to be a historic year for Bitcoin. It’s all thanks to three major catalysts that I reveal in my...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.